Bevacizumab/cetuximab: Hypertension and skin toxicity: case report

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1273, 2009-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bevacizumab/cetuximab: First report of ecchymosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1245, 2009-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Cetuximab: Skin eruptions: case report

By  

Reactions Weekly, Vol. 1, Iss. 1078, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Bevacizumab: First report of skin eruption: case report

By  

Reactions Weekly, Vol. 1, Iss. 1129, 2006-01 ,pp. : 6-7

Adis International

Access to resources Recommend Favorite

Sorafenib: Skin toxicity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 24-24

Adis International

Access to resources Recommend Favorite

Sorafenib: Skin toxicity: case report

By  

Reactions Weekly, Vol. 1, Iss. 1384, 2012-01 ,pp. : 53-53

Adis International

Access to resources Recommend Favorite